UPDATE: Carlsmed Q3 Adj. EPS $(0.34) Beats $(0.40) Estimate, Sales $21.554M Beat $19.154M Estimate
Benzinga Newsdesk 6 hours ago
NewsEarningsEarnings Beats
Carlsmed (NASDAQ:CARL) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.40) by 15 percent. This is a 15 percent increase over losses of $(0.40) per share from the same
Carlsmed (NASDAQ:CARL) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.40) by 15 percent. This is a 15 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $21.554 million which beat the analyst consensus estimate of $19.154 million by 12.53 percent. This is a 64.86 percent increase over sales of $13.074 million the same period last year.